DrugRepV Browse Page

DrugRepV browse page allows user to take a glance of the particular antiviral agent.Fields in the webpage is hylerlinked ot various external repositories like DrugBank, PubChem, Clinicaltrials.gov,and PubMed.User can explore the biological, Clinical, Chemical, and Structural details of every repurposed drug candidate.By clicking on the table header arrows, user can sort entries in ascending or descending order.


Total number of Records for Virus yield reduction assay are 95

DrugRepV_ID	Antiviral Name	Drug type	Primary Indication	Secondary Indication	Strain	Pathways	Assay	Activity	Clinical Status	References
DrugRepV_2129	Ribavirin	Antiinfectives For Systemic Use	Hepatitis C virus	Zika virus	MR766	NA	Virus yield reduction assay	Decrease (50 %)	Approved	27163257
DrugRepV_2131	Favipiravir	Antiviral	Influenza virus	Zika virus	MR766	NA	Virus yield reduction assay	Decrease (50 %)	Investigational	27163257
DrugRepV_2133	2-C-Methylcytidine	NA	Hepatitis C virus	Zika virus	MR766	NA	Virus yield reduction assay	Decrease (50 %)	Experimental	27163257
DrugRepV_2135	7-deaza-2-C-methyl-D-adenosine	NA	Viral infection	Zika virus	MR766	NA	Virus yield reduction assay	Decrease (50 %)	NA	27163257
DrugRepV_2141	BCX4430 Dihydrochloride	NA	Ebola virus	Zika virus	Puerto Rican strain PRVABC-59	NA	Virus yield reduction assay	Decrease (90 %)	Phase I	27838352
DrugRepV_2143	BCX4430 Dihydrochloride	NA	Ebola virus	Zika virus	Puerto Rican strain PRVABC-59	NA	Virus yield reduction assay	Decrease (90 %)	Phase I	27838352
DrugRepV_2145	BCX4430 Dihydrochloride	NA	Ebola virus	Zika virus	Puerto Rican strain PRVABC-59	NA	Virus yield reduction assay	Decrease (90 %)	Phase I	27838352
DrugRepV_2147	BCX4430 Dihydrochloride	NA	Ebola virus	Zika virus	Malaysian P 6-740	NA	Virus yield reduction assay	Decrease (90 %)	Phase I	27838352
DrugRepV_2149	BCX4430 Dihydrochloride	NA	Ebola virus	Zika virus	Malaysian P 6-740	NA	Virus yield reduction assay	Decrease (90 %)	Phase I	27838352
DrugRepV_2151	BCX4430 Dihydrochloride	NA	Ebola virus	Zika virus	Ugandan MR-766	NA	Virus yield reduction assay	Decrease (90 %)	Phase I	27838352
DrugRepV_2153	BCX4430 Dihydrochloride	NA	Ebola virus	Zika virus	Ugandan MR-766	NA	Virus yield reduction assay	Decrease (90 %)	Phase I	27838352
DrugRepV_2155	BCX4430 Dihydrochloride	NA	Ebola virus	Zika virus	Ugandan MR-766	NA	Virus yield reduction assay	Decrease (90 %)	Phase I	27838352
DrugRepV_3173	Mycophenolic Acid	Antineoplastic and Immunomodulating Agents	Organ rejection (immunosuppressants)	Chikungunya virus	DRDE-06	NA	Virus yield reduction assay	Decrease (50 %)	Approved	21070810
DrugRepV_3174	Mycophenolic Acid	Antineoplastic and Immunomodulating Agents	Organ rejection (immunosuppressants)	Chikungunya virus	DRDE-06	NA	Virus yield reduction assay	Decrease (50 %)	Approved	21070810
DrugRepV_3175	Mycophenolic Acid	Antineoplastic and Immunomodulating Agents	Organ rejection (immunosuppressants)	Chikungunya virus	DRDE-06	NA	Virus yield reduction assay	Decrease (50 %)	Approved	21070810
DrugRepV_3176	Mycophenolic Acid	Antineoplastic and Immunomodulating Agents	Organ rejection (immunosuppressants)	Chikungunya virus	DRDE-06	NA	Virus yield reduction assay	Decrease (50 %)	Approved	21070810
DrugRepV_3177	Mycophenolic Acid	Antineoplastic and Immunomodulating Agents	Organ rejection (immunosuppressants)	Chikungunya virus	DRDE-06	NA	Virus yield reduction assay	Decrease (50 %)	Approved	21070810
DrugRepV_3515	Nitazoxanide	Antiparasitic products, Insectisides and Repellents	Diarrhea	Influenza virus	A/Ohio/88/2012		Virus yield reduction assay	Decrease (90 %)	Approved, Investigational, Vet approved	24449767
DrugRepV_3516	Nitazoxanide	Antiparasitic products, Insectisides and Repellents	Diarrhea	Influenza virus	A/Ohio/83/2012		Virus yield reduction assay	Decrease (90 %)	Approved, Investigational, Vet approved	24449767
DrugRepV_3517	Nitazoxanide	Antiparasitic products, Insectisides and Repellents	Diarrhea	Influenza virus	A/Washington/01/2007		Virus yield reduction assay	Decrease (90 %)	Approved, Investigational, Vet approved	24449767
DrugRepV_3518	Nitazoxanide	Antiparasitic products, Insectisides and Repellents	Diarrhea	Influenza virus	A/Texas/12/2007		Virus yield reduction assay	Decrease (90 %)	Approved, Investigational, Vet approved	24449767
DrugRepV_3519	Nitazoxanide	Antiparasitic products, Insectisides and Repellents	Diarrhea	Influenza virus	A/California/04/2009		Virus yield reduction assay	Decrease (90 %)	Approved, Investigational, Vet approved	24449767
DrugRepV_3520	Favipiravir	Antiviral	Influenza virus	Influenza virus	A/Ohio/88/2012		Virus yield reduction assay	Decrease (90 %)	Investigational	24449767
DrugRepV_3521	Favipiravir	Antiviral	Influenza virus	Influenza virus	A/Ohio/83/2012		Virus yield reduction assay	Decrease (90 %)	Investigational	24449767
DrugRepV_3522	Favipiravir	Antiviral	Influenza virus	Influenza virus	A/Washington/01/2007		Virus yield reduction assay	Decrease (90 %)	Investigational	24449767
DrugRepV_3523	Favipiravir	Antiviral	Influenza virus	Influenza virus	A/Texas/12/2007		Virus yield reduction assay	Decrease (90 %)	Investigational	24449767
DrugRepV_3524	Favipiravir	Antiviral	Influenza virus	Influenza virus	A/California/04/2009		Virus yield reduction assay	Decrease (90 %)	Investigational	24449767
DrugRepV_3525	Fludase	Antiviral	Asthma and Bronchiectasis	Influenza virus	A/Ohio/88/2012		Virus yield reduction assay	Decrease (90 %)	Phase I	24449767
DrugRepV_3526	Fludase	Antiviral	Asthma and Bronchiectasis	Influenza virus	A/Ohio/83/2012		Virus yield reduction assay	Decrease (90 %)	Phase I	24449767
DrugRepV_3527	Fludase	Antiviral	Asthma and Bronchiectasis	Influenza virus	A/Washington/01/2007		Virus yield reduction assay	Decrease (90 %)	Phase I	24449767
DrugRepV_3528	Fludase	Antiviral	Asthma and Bronchiectasis	Influenza virus	A/Texas/12/2007		Virus yield reduction assay	Decrease (90 %)	Phase I	24449767
DrugRepV_3529	Fludase	Antiviral	Asthma and Bronchiectasis	Influenza virus	A/California/04/2009		Virus yield reduction assay	Decrease (90 %)	Phase I	24449767
DrugRepV_4777	Mycophenolic Acid	Antineoplastic and Immunomodulating Agents	Organ rejection (immunosuppressants)	Middle East respiratory syndrome coronavirus	Hu/Jordan-N3/2012	NA	Virus yield reduction assay	Decrease (50 %)	Approved	24323636
DrugRepV_4778	Ribavirin	Antiinfectives For Systemic Use	Hepatitis C virus	Middle East respiratory syndrome coronavirus	Hu/Jordan-N3/2012	NA	Virus yield reduction assay	Decrease (30 %)	Approved	24323636
DrugRepV_4779	IFN-beta	Antineoplastic and Immunomodulating Agents	NA	Middle East respiratory syndrome coronavirus	Hu/Jordan-N3/2012	NA	Virus yield reduction assay	Decrease (50 %)	NA	24323636
DrugRepV_4780	IFN-alpha2a	Antineoplastic and Immunomodulating Agents	Hepatitis C virus | Hairy cell leukemia | AIDS-related Kaposi's sarcoma | Leukemia	Middle East respiratory syndrome coronavirus	Hu/Jordan-N3/2012	NA	Virus yield reduction assay	Decrease (50 %)	Approved, Investigational	24323636
DrugRepV_4781	IFN-alpha2b	Antineoplastic and Immunomodulating Agents	Hairy cell leukemia | Malignant melanoma | AIDS-related Kaposi's sarcoma	Middle East respiratory syndrome coronavirus	Hu/Jordan-N3/2012	NA	Virus yield reduction assay	Decrease (50 %)	Approved	24323636
DrugRepV_4782	IFN-universal	NA	NA	Middle East respiratory syndrome coronavirus	Hu/Jordan-N3/2012	NA	Virus yield reduction assay	Decrease (50 %)	NA	24323636
DrugRepV_4783	IFN-gamma	Antineoplastic and Immunomodulating Agents	NA	Middle East respiratory syndrome coronavirus	Hu/Jordan-N3/2012	NA	Virus yield reduction assay	Decrease (50 %)	NA	24323636
DrugRepV_5068	Alisporivir	NA	Hepatitis C virus	Middle East respiratory syndrome coronavirus	EMC/2012	NA	Virus yield reduction assay	Decrease (50 %)	Investigational	27840112
DrugRepV_6144	5,7-dichloro-2-(propan-2-yl)quinolin-8-ol	NA	NA	Dengue virus	NA		Virus yield reduction assay	Decrease (50 %)	NA	29547522
DrugRepV_6145	5,7-dichloro-2-(2-methylpropyl)quinolin-8-ol	NA	NA	Dengue virus	NA		Virus yield reduction assay	Decrease (50 %)	NA	29547522
DrugRepV_6170	4-[1-(4-{[1,1-biphenyl]-4-yl}-1,3-thiazol-2-yl)-5-phenyl-4,5-dihydro-1H-pyrazol-3-yl]phenol	NA	NA	Dengue virus	NA		Virus yield reduction assay	Decrease (50 %)	NA	25791449
DrugRepV_6171	4-[1-(4-{[1,1-biphenyl]-4-yl}-1,3-thiazol-2-yl)-3-(4-methoxyphenyl)-4,5-dihydro-1H-pyrazol-5-yl]-2-methoxyphenol	NA	NA	Dengue virus	NA		Virus yield reduction assay	Decrease (50 %)	NA	25791449
DrugRepV_6172	4-[1-(4-{[1,1-biphenyl]-4-yl}-1,3-thiazol-2-yl)-3-(4-methoxyphenyl)-4,5-dihydro-1H-pyrazol-5-yl]phenol	NA	NA	Dengue virus	NA		Virus yield reduction assay	Decrease (50 %)	NA	25791449
DrugRepV_6173	4-[(1E)-1-{2-[4-(4-chlorophenyl)-1,3-thiazol-2-yl]hydrazin-1-ylidene}ethyl]phenol	NA	NA	Dengue virus	NA		Virus yield reduction assay	Decrease (50 %)	NA	25791449
DrugRepV_6174	4-{[1,1-biphenyl]-4-yl}-2-[(2E)-2-[1-(4-methoxyphenyl)ethylidene]hydrazin-1-yl]-1,3-thiazole	NA	NA	Dengue virus	NA		Virus yield reduction assay	Decrease (50 %)	NA	25791449
DrugRepV_6175	4-{[1,1-biphenyl]-4-yl}-2-[(2E)-2-[1-(4-nitrophenyl)ethylidene]hydrazin-1-yl]-1,3-thiazole	NA	NA	Dengue virus	NA		Virus yield reduction assay	Decrease (50 %)	NA	25791449
DrugRepV_6177	4-[(E)-[2-(4-{[1,1-biphenyl]-4-yl}-1,3-thiazol-2-yl)hydrazin-1-ylidene]methyl]phenol	NA	NA	Dengue virus	NA		Virus yield reduction assay	Decrease (50 %)	NA	25791449
DrugRepV_6184	UV-4B	NA	NA	Dengue virus	NA		Virus yield reduction assay	Decrease (50 %)	NA	26946111
DrugRepV_6185	UV-4B	NA	NA	Dengue virus	16681		Virus yield reduction assay	Decrease (50 %)	NA	26946111
DrugRepV_6186	UV-4B	NA	NA	Dengue virus	NA		Virus yield reduction assay	Decrease (50 %)	NA	26946111
DrugRepV_6187	UV-4B	NA	NA	Dengue virus	NA		Virus yield reduction assay	Decrease (50 %)	NA	26946111
DrugRepV_6193	STK332077	NA	NA	Dengue virus	New Guinea C (NGC)		Virus yield reduction assay	Decrease (50 %)	NA	26807547
DrugRepV_6194	STK529754	NA	NA	Dengue virus	New Guinea C (NGC)		Virus yield reduction assay	Decrease (50 %)	NA	26807547
DrugRepV_6195	STK530661	NA	NA	Dengue virus	New Guinea C (NGC)		Virus yield reduction assay	Decrease (50 %)	NA	26807547
DrugRepV_6280	G3d	NA	NA	Dengue virus	NGC		Virus yield reduction assay	Decrease (50 %)	NA	15911027
DrugRepV_6281	C2S-3	NA	NA	Dengue virus	NGC		Virus yield reduction assay	Decrease (50 %)	NA	15911027
DrugRepV_6282	Heparin	Blood and Blood Forming Organs	Venous thrombosis	Dengue virus	NGC		Virus yield reduction assay	Decrease (50 %)	Approved, Investigational	15911027
DrugRepV_6283	DS8000	NA	NA	Dengue virus	NGC		Virus yield reduction assay	Decrease (50 %)	NA	15911027
DrugRepV_6284	G3d	NA	NA	Dengue virus	NGC		Virus yield reduction assay	Decrease (50 %)	NA	15911027
DrugRepV_6285	C2S-3	NA	NA	Dengue virus	NGC		Virus yield reduction assay	Decrease (50 %)	NA	15911027
DrugRepV_6286	Heparin	Blood and Blood Forming Organs	Venous thrombosis	Dengue virus	NGC		Virus yield reduction assay	Decrease (50 %)	Approved, Investigational	15911027
DrugRepV_6287	DS8000	NA	NA	Dengue virus	NGC		Virus yield reduction assay	Decrease (50 %)	NA	15911027
DrugRepV_6288	G3d	NA	NA	Dengue virus	NGC		Virus yield reduction assay	Decrease (50 %)	NA	15911027
DrugRepV_6289	C2S-3	NA	NA	Dengue virus	NGC		Virus yield reduction assay	Decrease (50 %)	NA	15911027
DrugRepV_6290	Heparin	Blood and Blood Forming Organs	Venous thrombosis	Dengue virus	NGC		Virus yield reduction assay	Decrease (50 %)	Approved, Investigational	15911027
DrugRepV_6291	DS8000	NA	NA	Dengue virus	NGC		Virus yield reduction assay	Decrease (50 %)	NA	15911027
DrugRepV_6292	G3d	NA	NA	Dengue virus	NGC		Virus yield reduction assay	Decrease (50 %)	NA	15911027
DrugRepV_6293	C2S-3	NA	NA	Dengue virus	NGC		Virus yield reduction assay	Decrease (50 %)	NA	15911027
DrugRepV_6294	Heparin	Blood and Blood Forming Organs	Venous thrombosis	Dengue virus	NGC		Virus yield reduction assay	Decrease (50 %)	Approved, Investigational	15911027
DrugRepV_6295	DS8000	NA	NA	Dengue virus	NGC		Virus yield reduction assay	Decrease (50 %)	NA	15911027
DrugRepV_6296	G3d	NA	NA	Dengue virus	H87		Virus yield reduction assay	Decrease (50 %)	NA	15911027
DrugRepV_6297	C2S-3	NA	NA	Dengue virus	H87		Virus yield reduction assay	Decrease (50 %)	NA	15911027
DrugRepV_6298	Heparin	Blood and Blood Forming Organs	Venous thrombosis	Dengue virus	H87		Virus yield reduction assay	Decrease (50 %)	Approved, Investigational	15911027
DrugRepV_6299	DS8000	NA	NA	Dengue virus	H87		Virus yield reduction assay	Decrease (50 %)	NA	15911027
DrugRepV_6300	G3d	NA	NA	Dengue virus	H87		Virus yield reduction assay	Decrease (50 %)	NA	15911027
DrugRepV_6301	C2S-3	NA	NA	Dengue virus	H87		Virus yield reduction assay	Decrease (50 %)	NA	15911027
DrugRepV_6302	Heparin	Blood and Blood Forming Organs	Venous thrombosis	Dengue virus	H87		Virus yield reduction assay	Decrease (50 %)	Approved, Investigational	15911027
DrugRepV_6303	DS8000	NA	NA	Dengue virus	H87		Virus yield reduction assay	Decrease (50 %)	NA	15911027
DrugRepV_6304	G3d	NA	NA	Dengue virus	H87		Virus yield reduction assay	Decrease (50 %)	NA	15911027
DrugRepV_6305	C2S-3	NA	NA	Dengue virus	H87		Virus yield reduction assay	Decrease (50 %)	NA	15911027
DrugRepV_6306	Heparin	Blood and Blood Forming Organs	Venous thrombosis	Dengue virus	H87		Virus yield reduction assay	Decrease (50 %)	Approved, Investigational	15911027
DrugRepV_6307	DS8000	NA	NA	Dengue virus	H87		Virus yield reduction assay	Decrease (50 %)	NA	15911027
DrugRepV_6308	G3d	NA	NA	Dengue virus	H87		Virus yield reduction assay	Decrease (50 %)	NA	15911027
DrugRepV_6309	C2S-3	NA	NA	Dengue virus	H87		Virus yield reduction assay	Decrease (50 %)	NA	15911027
DrugRepV_6310	Heparin	Blood and Blood Forming Organs	Venous thrombosis	Dengue virus	H87		Virus yield reduction assay	Decrease (50 %)	Approved, Investigational	15911027
DrugRepV_6311	DS8000	NA	NA	Dengue virus	H87		Virus yield reduction assay	Decrease (50 %)	NA	15911027
DrugRepV_7313	CW-33A	NA	NA	Japanese encephalitis virus	T1P1		Virus yield reduction assay	Decrease (50 %)	NA	30413749
DrugRepV_7314	CW-33	NA	NA	Japanese encephalitis virus	T1P1		Virus yield reduction assay	Decrease (50 %)	NA	30413749
DrugRepV_7509	6-Azauridine	NA	Cancer	West Nile virus	New York		Virus yield reduction assay	Decrease (90 %)	NA	12076755
DrugRepV_7510	Pyrazofurin	NA	NA	West Nile virus	New York		Virus yield reduction assay	Decrease (90 %)	NA	12076755
DrugRepV_7511	Ribavirin	Antiinfectives For Systemic Use	Hepatitis C virus	West Nile virus	New York		Virus yield reduction assay	Decrease (90 %)	Approved	12076755
DrugRepV_7512	Mycophenolic Acid	Antineoplastic and Immunomodulating Agents	Organ rejection (immunosuppressants)	West Nile virus	New York		Virus yield reduction assay	Decrease (90 %)	Approved	12076755
DrugRepV_7513	Cyclopentenylcytosine	NA	NA	West Nile virus	New York		Virus yield reduction assay	Decrease (90 %)	NA	12076755